Renaud Ronald C JR

CIK 00013544349 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001354434

Recent Transactions

50 trades

Award
Upstream Bio, Inc.$UPB
Stock Option (Right to Buy)
2025-06-10+17,096→ 17,096 total
Award
Upstream Bio, Inc.$UPB
Stock Option (Right to Buy)
2024-10-10+17,096→ 17,096 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Performance-based Restricted Stock Units
2024-08-01−320,742→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-08-01−83,857→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-08-01−160,452→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-08-01−215,749→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2024-08-01−284,023→ 0 total
Award
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2024-01-19+284,023→ 284,023 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-12-19+160,452→ 160,452 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2023-12-19−160,452→ 0 total
Purchase
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-08-03$23.96/sh+83,857→ 83,857 total
Award
Cerevel Therapeutics Holdings, Inc.
Performance-based Restricted Stock Units
2023-06-12+160,371→ 160,371 total
Award
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2023-06-12+160,452→ 160,452 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2023-06-12+215,749→ 215,749 total
Award
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2022-06-23+20,500→ 31,500 total
Award
Atara Biotherapeutics, Inc.$ATRA
Non-Qualified Stock Option (Right to Buy)
2022-06-23+31,500→ 31,500 total
Award
ImageneBio, Inc.$IMA
Stock Option (Right to Buy)
2022-06-09+13,419→ 13,419 total
Award
ImageneBio, Inc.$IMA
Stock Option (Right to Buy)
2021-12-21+13,419→ 13,419 total
Sale
Translate Bio, Inc.
Stcok Option (right to buy)
2021-09-14−325,000→ 0 total
Sale
Translate Bio, Inc.
Common Stock
2021-09-14$38.00/sh−409,913→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−1,071,009→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−89,996→ 0 total
Sale
Translate Bio, Inc.
Common Stock
2021-09-14$38.00/sh−503,231→ 0 total
Sale
Translate Bio, Inc.
Common Stock
2021-09-14$38.00/sh−40,909→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−525,000→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−500,000→ 0 total
Award
Atara Biotherapeutics, Inc.$ATRA
Non-Qualified Stock Option (Right to Buy)
2021-06-08+17,500→ 17,500 total
Award
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2021-06-08+11,000→ 11,000 total
Exercise/Conversion
Translate Bio, Inc.
Common Stock
2021-04-07$7.39/sh+9,026→ 503,231 total
Exercise/Conversion
Translate Bio, Inc.
Common Stock
2021-04-07$7.39/sh+9,026→ 503,321 total
Exercise/Conversion
Translate Bio, Inc.
Stock Option (right to buy)
2021-04-07−9,026→ 1,071,009 total
Exercise/Conversion
Translate Bio, Inc.
Stock Option (right to buy)
2021-04-07−9,026→ 1,071,009 total
Award
Translate Bio, Inc.
Stock Option (right to buy)
2021-03-09+325,000→ 325,000 total
Exercise/Conversion
Translate Bio, Inc.
Common Stock
2021-01-14$8.34/sh+1→ 494,205 total
Exercise/Conversion
Translate Bio, Inc.
Stock Option (right to buy)
2021-01-14−5,638→ 1,080,035 total
Exercise/Conversion
Translate Bio, Inc.
Common Stock
2021-01-14$7.39/sh+5,638→ 494,204 total
Exercise/Conversion
Translate Bio, Inc.
Stock Option (right to buy)
2021-01-14−1→ 89,996 total
Exercise/Conversion
Translate Bio, Inc.
Common Stock
2020-11-16$7.39/sh+53,004→ 488,563 total
Exercise/Conversion
Translate Bio, Inc.
Common Stock
2020-11-16$8.34/sh+3→ 488,566 total
Exercise/Conversion
Translate Bio, Inc.
Stock Option (right to buy)
2020-11-16−53,004→ 1,085,673 total
Exercise/Conversion
Translate Bio, Inc.
Stock Option (right to buy)
2020-11-16−3→ 89,997 total
Award
Atara Biotherapeutics, Inc.$ATRA
Non-Qualified Stock Option (Right to Buy)
2020-04-29+71,500→ 71,500 total
Award
Translate Bio, Inc.
Stock Option (right to buy)
2020-03-03+525,000→ 525,000 total
Award
CHIMERIX INC
Stock Option (Right to Buy)
2019-06-20+21,000→ 21,000 total
Award
Translate Bio, Inc.
Stock Option (right to buy)
2019-03-08+500,000→ 500,000 total
Conversion
Translate Bio, Inc.
Common Stock
2018-07-02+40,909→ 409,913 total
Conversion
Translate Bio, Inc.
Series C Preferred Stock
2018-07-02−227,272→ 0 total
Conversion
Translate Bio, Inc.
Common Stock
2018-07-02+40,909→ 40,909 total
Conversion
Translate Bio, Inc.
Series C Preferred Stock
2018-07-02−227,272→ 0 total
Award
CHIMERIX INC
Stock Option (Right to Buy)
2018-06-20+21,000→ 21,000 total

Renaud Ronald C JR

Recent Transactions

Companies

Recent Filings

Address